These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37596528)

  • 21. Comprehensive analysis of transient receptor potential channels-related signature for prognosis, tumor immune microenvironment, and treatment response of colorectal cancer.
    Wang L; Chen X; Zhang H; Hong L; Wang J; Shao L; Chen G; Wu J
    Front Immunol; 2022; 13():1014834. PubMed ID: 36389750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrative analysis revealed that distinct cuprotosis patterns reshaped tumor microenvironment and responses to immunotherapy of colorectal cancer.
    Xu X; Ding C; Zhong H; Qin W; Shu D; Yu M; Abuduaini N; Zhang S; Yang X; Feng B
    Front Immunol; 2023; 14():1165101. PubMed ID: 37006250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
    Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
    Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor microenvironment characterization in cervical cancer identifies prognostic relevant gene signatures.
    Peng L; Hayatullah G; Zhou H; Chang S; Liu L; Qiu H; Duan X; Han L
    PLoS One; 2021; 16(4):e0249374. PubMed ID: 33901225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel identified pyroptosis-related prognostic signature of colorectal cancer.
    Zheng C; Tan Z
    Math Biosci Eng; 2021 Oct; 18(6):8783-8796. PubMed ID: 34814322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma.
    Liang Z; Sun R; Tu P; Liang Y; Liang L; Liu F; Bian Y; Yin G; Zhao F; Jiang M; Gu J; Tang D
    Front Immunol; 2022; 13():944286. PubMed ID: 36591255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An immune landscape based prognostic signature predicts the immune status and immunotherapeutic responses of patients with colorectal cancer.
    Li M; Li W; Yang X; Wang H; Peng Y; Yin J; Lu Y; Liu L; Shang J; Zhao Q
    Life Sci; 2020 Nov; 261():118368. PubMed ID: 32888940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the Immune Cell Infiltration Landscape Uncovers Prognostic and Immunogenic Characteristics in Lung Adenocarcinoma.
    Wang X; Xu Z; Liu Z; Lin W; Cao Z; Feng X; Gao Y; He J
    Front Genet; 2022; 13():902577. PubMed ID: 35677561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leveraging Tumor Microenvironment Infiltration in Pancreatic Cancer to Identify Gene Signatures Related to Prognosis and Immunotherapy Response.
    Yang J; Zeng L; Chen R; Huang L; Wu Z; Yu M; Zhou Y; Chen R
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer.
    Zeng D; Wu J; Luo H; Li Y; Xiao J; Peng J; Ye Z; Zhou R; Yu Y; Wang G; Huang N; Wu J; Rong X; Sun L; Sun H; Qiu W; Xue Y; Bin J; Liao Y; Li N; Shi M; Kim KM; Liao W
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34376552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
    Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
    Front Immunol; 2022; 13():951455. PubMed ID: 36189298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constructing a Tregs-associated signature to predict the prognosis of colorectal cancer patients: A STROBE-compliant retrospective study.
    Ping G; Tian Y; Zhou Z
    Medicine (Baltimore); 2022 Nov; 101(47):e31382. PubMed ID: 36451426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor microenvironment characterization in esophageal cancer identifies prognostic relevant immune cell subtypes and gene signatures.
    Zhang Y; Zhu M; Mo J; Xian L
    Aging (Albany NY); 2021 Dec; 13(24):26118-26136. PubMed ID: 34954689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor microenvironment characterization in triple-negative breast cancer identifies prognostic gene signature.
    Qin Y; Deng J; Zhang L; Yuan J; Yang H; Li Q
    Aging (Albany NY); 2021 Feb; 13(4):5485-5505. PubMed ID: 33536349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyamine metabolism patterns characterized tumor microenvironment, prognosis, and response to immunotherapy in colorectal cancer.
    Zhang E; Ding C; Li S; Aikemu B; Zhou X; Fan X; Sun J; Yang X; Zheng M
    Cancer Cell Int; 2023 May; 23(1):96. PubMed ID: 37202800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor Microenvironment Profiling Identifies Prognostic Signatures and Suggests Immunotherapeutic Benefits in Neuroblastoma.
    Feng C; Li T; Xiao J; Wang J; Meng X; Niu H; Jiang B; Huang L; Deng X; Yan X; Wu D; Fang Y; Lin Y; Chen F; Wu X; Zhao X; Feng J
    Front Cell Dev Biol; 2022; 10():814836. PubMed ID: 35493068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of m6A Methylation Modification Patterns in Colorectal Cancer Determines Prognosis and Tumor Microenvironment Infiltration.
    Yue Q; Zhang Y; Wang F; Cao F; Bai J; Duan X
    J Immunol Res; 2022; 2022():8766735. PubMed ID: 35692505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer.
    Sun M; Ji X; Xie M; Chen X; Zhang B; Luo X; Feng Y; Liu D; Wang Y; Li Y; Liu B; Xia L; Huang W
    Front Immunol; 2022; 13():999084. PubMed ID: 36544770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the Tumor Microenvironment in Osteosarcoma Identifies Prognostic- and Immunotherapy-Relevant Gene Signatures.
    Tan J; Feng X; Wu H; Yang B; Shi M; Xie C; Su Z; Li L; Luo M; Zuo Z; Zhu S; Yang J; Lin L
    J Immunol Res; 2022; 2022():6568278. PubMed ID: 36065454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.